Cargando…

Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity

β-Agarase cleaves the β-1,4 linkages of agar to produce neoagarooligosaccharides (NAO), which are associated with various physiological functions. However, the immunological functions of NAO are still unclear. In this study, we demonstrated that β-agarase DagA-produced neoagarohexaose (DP6), an NAO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Moon Hee, Jang, Jong-Hwa, Yoon, Gun Young, Lee, Seung Jun, Lee, Min-Goo, Kang, Tae Heung, Han, Hee Dong, Kim, Hyuk Soon, Choi, Wahn Soo, Park, Won Sun, Park, Yeong-Min, Jung, In Duk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458676/ https://www.ncbi.nlm.nih.gov/pubmed/28287066 http://dx.doi.org/10.5483/BMBRep.2017.50.5.014

Ejemplares similares

Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy
por: Han, Hee Dong, et al.
Publicado: (2016)

The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4
por: Lee, Su Jung, et al.
Publicado: (2014)

Deoxypodophyllotoxin Induces a Th1 Response and Enhances the Antitumor Efficacy of a Dendritic Cell-based Vaccine
por: Lee, Jun Sik, et al.
Publicado: (2011)

Mycobacterium abscessus MAB2560 induces maturation of dendritic cells via Toll-like receptor 4 and drives Th1 immune response
por: Lee, Su Jung, et al.
Publicado: (2014)

A novel IL-10-producing innate lymphoid cells (ILC10) in a contact hypersensitivity mouse model
por: Kim, Hyuk Soon, et al.
Publicado: (2016)

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
por: Park, Hyun Jin, et al.
Publicado: (2019)

A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
por: Lee, Seung Jun, et al.
Publicado: (2014)

Mycobacterium abscessus ᴅ-alanyl-ᴅ-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity
por: Lee, Seung Jun, et al.
Publicado: (2016)

Interactions between tumor-derived proteins and Toll-like receptors
por: Jang, Gun-Young, et al.
Publicado: (2020)

The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency
por: Noh, Kyung Tae, et al.
Publicado: (2012)

Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8(+) T cells
por: Park, Sung Nam, et al.
Publicado: (2013)

Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
por: Kang, Tae Heung, et al.
Publicado: (2015)

Heat shock protein X purified from Mycobacterium tuberculosis enhances the efficacy of dendritic cells-based immunotherapy for the treatment of allergic asthma
por: Kim, Hye-young, et al.
Publicado: (2015)

Natural Killer Dendritic Cells Enhance Immune Responses Elicited by α-Galactosylceramide-Stimulated Natural Killer T Cells
por: Lee, Sung Won, et al.
Publicado: (2013)

Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge
por: You, Eunkyoung, et al.
Publicado: (2023)

ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
por: Park, Joo Dong, et al.
Publicado: (2022)

Extracellular Production of a Novel Endo-β-Agarase AgaA from Pseudomonas vesicularis MA103 that Cleaves Agarose into Neoagarotetraose and Neoagarohexaose
por: Hsu, Pang-Hung, et al.
Publicado: (2015)

Entinostat, a histone deacetylase inhibitor, increases the population of IL-10(+) regulatory B cells to suppress contact hypersensitivity
por: Min, Keun Young, et al.
Publicado: (2021)

Repositioning of the antipsychotic drug TFP for sepsis treatment
por: Park, Jung Hwa, et al.
Publicado: (2019)

Drug repositioning of anti-microbial agent nifuratel to treat mast cell-mediated allergic responses
por: Lee, Ji Eon, et al.
Publicado: (2023)

CD1d(hi)PD-L1(hi)CD27(+) Regulatory Natural Killer Subset Suppresses Atopic Dermatitis
por: Min, Keun Young, et al.
Publicado: (2022)

Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model
por: Tran, Thi-Anh-Thuy, et al.
Publicado: (2023)

Blastic Plasmacytoid Dendritic Cell Neoplasm: Analysis of Clinicopathological Feature and Treatment Outcome of Seven Cases
por: Kim, Jun-Hwan, et al.
Publicado: (2015)

Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40(hi)CD5(+) regulatory B cells in vitro and in vivo
por: Kim, Hyuk Soon, et al.
Publicado: (2015)

Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches
por: Won, Ji Eun, et al.
Publicado: (2022)

25KDa branched polyethylenimine increases interferon-γ production in natural killer cells via improving translation efficiency
por: Ko, Eun-Su, et al.
Publicado: (2023)

Anti-cancer activity of Angelica gigas by increasing immune response and stimulating natural killer and natural killer T cells
por: Kim, Seo Hyun, et al.
Publicado: (2018)

Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model
por: Kim, Hyun-Ah, et al.
Publicado: (2023)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
por: Dhodapkar, Kavita M., et al.
Publicado: (2002)

Canine Natural Killer Cell-Derived Exosomes Exhibit Antitumor Activity in a Mouse Model of Canine Mammary Tumor
por: Lee, Jienny, et al.
Publicado: (2021)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Outer membrane protein a of Salmonella enterica serovar Typhimurium activates dendritic cells and enhances Th1 polarization
por: Lee, Jun Sik, et al.
Publicado: (2010)

Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy
por: Choi, Seung Hee, et al.
Publicado: (2022)

Lactoferrin Induces Tolerogenic Bone Marrow-Derived Dendritic Cells
por: Park, Hui-Won, et al.
Publicado: (2020)

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
por: Park, Yeong-Min, et al.
Publicado: (2013)

Plasmacytoid dendritic cell neoplasms
por: Lee, Yoo Jin, et al.
Publicado: (2023)

Optimization of the ultrasound-assisted extraction of flavonoids and the antioxidant activity of Ruby S apple peel using the response surface method
por: Park, NaYeong, et al.
Publicado: (2022)

Upregulation of Toll-like Receptor 2 in Dental Primary Afferents Following Pulp Injury
por: Lee, Pa Reum, et al.
Publicado: (2021)

CD8α+ dendritic cells potentiate antitumor and immune activities against murine ovarian cancers
por: Lee, Shin-Wha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ugv9f24pqclibbpn5n1okoq2cr